Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00277069 · ClinicalTrials.gov registry record · Phase 1
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
A Phase 1 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT00277069 is a Phase 1 study that has completed, run by University of New Mexico. The registered enrollment target is 33 participants.
The verdict
NCT00277069, a Phase 1 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
1\. Determine the response rate with this regimen in an anthracycline and taxane resistant cohort of patients.
Interventions
- DRUG Carboplatin
- DRUG Vinorelbine
- DEVICE Capecitabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2000-05 |
| Est. Completion | 2006-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00277069
The ClinicalTrials.gov registry entry for NCT00277069 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Carboplatin is the first listed.
NCT00277069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00277069 about?
NCT00277069 is a clinical study titled "Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer". 1\. Determine the response rate with this regimen in an anthracycline and taxane resistant cohort of patients.
What is the current status of trial NCT00277069?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2000-05. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00277069?
The interventions under investigation include: Carboplatin (DRUG), Vinorelbine (DRUG), Capecitabine (DEVICE).
Who is sponsoring clinical trial NCT00277069?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.